article: 27
This data as json
| rowid | title | DOI | URL | created | subject | references-count | is-referenced-by-count | ISSN | container-title | abstract | author_number | orcids | names | award_numbers | funder_names | funder_dois |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27 | ["Guideline review: British Society of Gastroenterology/UK-PBC Primary Biliary Cholangitis treatment and management guidelines"] | 10.1136/flgastro-2018-101109 | http://dx.doi.org/10.1136/flgastro-2018-101109 | 2019-01-09T22:19:25Z | [] | 11 | 4 | ["2041-4137", "2041-4145"] | Frontline Gastroenterology | <jats:p>New guidelines have been produced for the management of primary biliary cholangitis, an infrequent but nonetheless important autoimmune liver disease. We provide a succient commentary and overview of the key features of disease management that arise from these recent guideline recommendations, with a focus on therapy with licensed agents (ursodeoxycholic acid and obeticholic acid) as well as personalised management of disease complications and associated symptoms.</jats:p> | 2 | ["http://orcid.org/0000-0002-6054-569X"] | ["Jorn C Goet", "Gideon M Hirschfield"] | [""] | [""] | [""] |